1. Bergman P, et al. (2012). Vitamin D3 supplementation in patients with frequent respiratory tract infections. BMJ open, 2(6), e001663.
2. Muris AH, et al. (2016). Immune regulatory effects of high dose vitamin D3 supplementation in multiple sclerosis patients. Journal of neuroimmunology, 300, 47-56.
3. Myneni VD, Mezey E. (2018). Immunomodulatory effect of vitamin K2. Oral diseases, 24(1-2), 67-71.
4. Schroten NF, et al. (2013). Short-term vitamin D3 supplementation in heart failure patients. American heart journal, 166(2), 357-64.
5. Vermeer C, Vik H. (2020). Effect of Menaquinone-7 (vitamin K2) on vascular elasticity. Vasc Dis Ther, 5, 1-4.
6. Aoun M, et al. (2017). High dephosphorylated-uncarboxylated MGP in hemodialysis patients. BMC nephrology, 18, 1-0.
7. Vermeer C, Vik H. (2020). Effect of Menaquinone-7 (vitamin K2) on vascular elasticity. Vasc Dis Ther, 5, 1-4.
8. Mager DR, et al. (2017). Vitamin D3 supplementation, bone health in diabetic kidney disease patients. Clinical nutrition, 36(3), 686-96.
9. van Summeren MJ, et al. (2009). Menaquinone-7 supplementation in prepubertal children. British journal of nutrition, 102(8), 1171-8.
10. Knapen MH, et al. (2013). Three-year low-dose menaquinone-7 supplementation in postmenopausal women. Osteoporosis International, 24(9), 2499-507.
11. Schurgers LJ, et al. (2007). Vitamin K–containing dietary supplements: comparison of synthetic vitamin K1 and menaquinone-7. Blood, 109(8), 3279-83.